A drug interaction between fusidic acid and a combination of ritonavir and saquinavir

被引：0
|
作者：
Khaliq, Y
Gallicano, K
Leger, R
Foster, B
Badley, A
机构：
[1] Ottawa Gen Hosp, Clin Invest Unit, Ottawa, ON K1H 8L6, Canada
[2] Ottawa Gen Hosp, Res Inst, Ottawa, ON K1H 8L6, Canada
[3] Univ Ottawa, Ottawa, ON, Canada
[4] Hlth Canada, Specialisees Med Familiale, Ottawa, ON K1A 0L2, Canada
[5] Hlth Canada, Therapeut Prod Programme, Ottawa, ON K1A 0L2, Canada
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2000年 / 50卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：82 / 83
页数：2
相关论文
共 50 条
  • [41] Pharmacokinetic interaction between saquinavir and cyclosporine
    Brinkman, K
    Huysmans, F
    Burger, DM
    ANNALS OF INTERNAL MEDICINE, 1998, 129 (11) : 914 - 915
  • [42] Comparison of initial combination antiretroviral therapy with a single protease inhibitor, ritonavir and saquinavir, or efavirenz
    Lucas, GM
    Chaisson, RE
    Moore, RD
    AIDS, 2001, 15 (13) : 1679 - 1686
  • [43] Fusidic-acid/niraparibDrug toxicity and pancytopenia followed by drug-drug interaction: case report
    Reactions Weekly, 2023, 1974 (1) : 159 - 159
  • [44] Side-effects of ritonavir and its combination with saquinavir with special regard to renal function
    Witzke, O
    Plentz, A
    Schafers, RF
    Reinhardt, W
    Heemann, U
    Philipp, T
    AIDS, 1997, 11 (06) : 836 - 838
  • [45] Comparison of initial combination antiretroviral therapy with a single protease inhibitor, ritonavir and saquinavir, or efavirenz
    Lucas, GM
    Chaisson, RE
    Moore, RD
    CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) : 1205 - 1205
  • [46] LACK OF DRUG-DRUG INTERACTION BETWEEN MERICITABINE AND RITONAVIR-BOOSTED DANOPREVIR
    Moreira, S.
    Goelzer, P.
    Weigl, P.
    Badman, E.
    Poirer, A.
    Brennan, B. J.
    Chen, Y.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S22 - S22
  • [47] PAH Therapy In HIV: Lack Of Drug-Drug Interaction Between Ambrisentan And Ritonavir
    Gillies, H. C.
    Wang, X.
    Staehr, P.
    Zack, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [48] Drug-drug interaction between ritonavir and inhaled corticoid leading to hypercorticism in a child
    Logerot, S.
    Lepelley, M.
    Villier, C.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2016, 30 : 58 - 58
  • [49] Interaction between statins and fusidic acid: an analysis from literature and Vigibase® data
    Deljehier, T.
    Pariente, A.
    Miremont-Salame, G.
    Haramburu, F.
    Theophile, H.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2017, 31 : 63 - 64
  • [50] Atazanavir and lopinavir with ritonavir alone or in combination: analysis of pharmacokinetic interaction and predictors of drug exposure
    Di Giambenedetto, S.
    De Luca, A.
    Villani, P.
    Bacarelli, A.
    Ragazzoni, E.
    Regazzi, M.
    Cauda, R.
    Navarra, P.
    HIV MEDICINE, 2008, 9 (04) : 239 - 245
12345